Eiko Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2025 ,inter alia, to consider and approve Unaudited Financial Results ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eiko Lifesciences Ltd has informed BSE that its Board of Directors will meet on Friday, 31st October 2025, to consider and approve the Unaudited Financial Results (both Standalone and Consolidated) for the quarter and half year ended 30th September 2025. The filing is made under Regulation 29 of SEBI's Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015. The trading window for designated persons and their immediate relatives has already been closed from 1st October 2025 and will reopen 48 hours after the results are declared. The intimation is signed by Chintan Doshi, Company Secretary & Compliance Officer.
This is a routine advance notice and does not by itself contain any financial data or operational update. Investors should watch for the actual Q2/H1 FY26 results announcement on or after 31st October 2025 for any meaningful insight into the company's earnings performance.